535 related articles for article (PubMed ID: 9227787)
1. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
4. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
5. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
6. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
7. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
8. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of (99m)Tc-tetrofosmin imaging and ultrasonography in diagnosis of breast cancer: a comparative study].
Chen Q; An XY; Liang H
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):140-1. PubMed ID: 18227047
[TBL] [Abstract][Full Text] [Related]
10. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
13. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
14. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas.
Spanu A; Schillaci O; Meloni GB; Porcu A; Cottu P; Nuvoli S; Falchi A; Chessa F; Solinas ME; Madeddu G
Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
17. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
19. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography.
Usmani S; Niaz K; Maseeh-Uz-Zaman ; Niyaz K; Khan HA; Habib S; Kamal S
Nucl Med Commun; 2007 Nov; 28(11):842-6. PubMed ID: 17901766
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
